AfaSci, Inc. is a biopharmaceutical company focused on discovering and developing innovative therapies for pain management and neurological disorders. Based in the San Francisco Bay Area, AfaSci specializes in non-opioid, non-NSAID solutions to address chronic pain, neuropathic conditions, and central nervous system diseases. Their research is centered around peptide and small molecule drugs, with several promising preclinical candidates targeting specific ion channels and enzymes involved in pain and inflammation. With a strong intellectual property portfolio and strategic partnerships with academic institutions, AfaSci is dedicated to advancing novel treatments that aim to improve patients’ quality of life while reducing reliance on traditional painkillers.
Monday – Friday
9 AM – 5 PM EST
DISCLAIMER: ConductScience and affiliate products are NOT designed for human consumption, testing, or clinical utilization. They are designed for pre-clinical utilization only. Customers purchasing apparatus for the purposes of scientific research or veterinary care affirm adherence to applicable regulatory bodies for the country in which their research or care is conducted.
